Cargando…
Proton pump inhibitors induce changes in the gut microbiome composition of systemic lupus erythematosus patients
BACKGROUND: Currently, few studies focus on the association between gut microbiota and systemic lupus erythematosus (SLE), and much less studies consider the effect of drug usage. Proton pump inhibitors (PPIs) are commonly used to treat drug-related gastrointestinal damage in SLE patients. Therefore...
Autores principales: | Li, Xian-Bao, Chu, Xiu-Jie, Cao, Nv-Wei, Wang, Hua, Fang, Xin-Yu, Fan, Yin-Guang, Li, Bao-Zhu, Ye, Dong-Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9043501/ https://www.ncbi.nlm.nih.gov/pubmed/35477382 http://dx.doi.org/10.1186/s12866-022-02533-x |
Ejemplares similares
-
Altered gut fungi in systemic lupus erythematosus – A pilot study
por: Li, Bao-Zhu, et al.
Publicado: (2022) -
Proton pump inhibitor-induced subacute cutaneous lupus erythematosus
por: Sandholdt, LH, et al.
Publicado: (2014) -
Proton pump inhibitors affect the gut microbiome
por: Imhann, Floris, et al.
Publicado: (2016) -
Antimalarials may reduce cancer risk in patients with systemic lupus erythematosus: a systematic review and meta-analysis of prospective studies
por: Li, Xian-Bao, et al.
Publicado: (2021) -
Drug-Induced Subacute Cutaneous Lupus Erythematosus Associated with Proton Pump Inhibitors
por: Aggarwal, Nitish
Publicado: (2016)